MB, Levis & Associates’s UiPath PATH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
Sell
-50
Closed -$640 284
2025
Q2
$640 Hold
50
﹤0.01% 254
2025
Q1
$515 Hold
50
﹤0.01% 268
2024
Q4
$636 Hold
50
﹤0.01% 276
2024
Q3
$640 Hold
50
﹤0.01% 275
2024
Q2
$634 Hold
50
﹤0.01% 271
2024
Q1
$1.13K Hold
50
﹤0.01% 258
2023
Q4
$1.24K Hold
50
﹤0.01% 249
2023
Q3
$856 Hold
50
﹤0.01% 259
2023
Q2
$829 Hold
50
﹤0.01% 265
2023
Q1
$878 Hold
50
﹤0.01% 259
2022
Q4
$636 Buy
+50
New +$618 ﹤0.01% 242

Other funds holding PATH

MB, Levis & Associates's PATH Position: Q3 2025 in Review

MB, Levis & Associates sold out of UiPath (PATH) in Q3 2025, closing a stake of 50 shares — an estimated $640 sold.

MB, Levis & Associates first reported a position in PATH in Q4 2022 and held it in 11 quarters. The position peaked at $1.24K in Q4 2023. 473 funds tracked by Wall St. Rank hold PATH as of Q3 2025.

  • MB, Levis & Associates reported no remaining UiPath position as of Q3 2025 after selling out during the quarter.
  • MB, Levis & Associates sold 50 UiPath shares in Q3 2025, an estimated $640.
  • MB, Levis & Associates first reported a position in UiPath in Q4 2022 and held it in 11 quarters.
  • MB, Levis & Associates's UiPath position peaked at $1.24K in Q4 2023.
  • 473 funds tracked by Wall St. Rank held UiPath as of Q3 2025.

Based on MB, Levis & Associates's 13F filing for Q3 2025, filed 15 Oct 2025.